Impact of prior chemoradiotherapy-related variables on outcomes with durvalumab in unresectable Stage III NSCLC (PACIFIC)

Faivre-Finn, C; Spigel, DR; Senan, S; Langer, C; Perez, BA; Ozguroglu, M; Daniel, D; Villegas, A; Vicente, D; Hui, RN; Murakami, S; Paz-Ares, L; Broadhurst, H; Wadsworth, C; Dennis, PA; Antonia, SJ

Faivre-Finn, C (corresponding author), Christie NHS Fdn Trust, Wilmslow Rd, Manchester M20 4BX, Lancs, England.

LUNG CANCER, 2021; 151 (): 30

Abstract

Introduction: The PACIFIC trial demonstrated that durvalumab significantly improved progression-free and overall survival (PFS/OS), versus placebo, in......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索